US Stock MarketDetailed Quotes

COEP Coeptis Therapeutics

Watchlist
  • 0.299
  • +0.008+2.68%
Close Jul 12 16:00 ET
  • 0.299
  • 0.0000.00%
Post 16:01 ET
11.10MMarket Cap-586P/E (TTM)

Coeptis Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.94%-1.9M
-86.79%-7.24M
-99.89%-1.69M
-89.54%-1.96M
-84.12%-1.9M
-75.15%-1.68M
13.67%-3.88M
-305.67%-847.35K
71.69%-1.03M
-4,259.21%-1.03M
Net income from continuing operations
62.28%-3M
43.40%-21.27M
-27.61%-3.76M
-12.42%-6.35M
67.33%-3.2M
58.51%-7.96M
-179.38%-37.57M
-3.64%-2.94M
5.01%-5.65M
-261.30%-9.8M
Operating gains losses
-101.07%-26.73K
-92.76%2.05M
-85.12%354.03K
-132.62%-1.09M
-96.54%286.5K
-82.46%2.5M
429.58%28.26M
-2.30%2.38M
45.76%3.36M
--8.28M
Depreciation and amortization
-0.04%250.21K
-0.01%1M
-0.01%250.31K
-0.01%250.31K
-0.01%250.31K
-0.01%250.31K
123.82%1M
-43.89%250.35K
68,300.55%250.35K
68,114.17%250.35K
Other non cash items
-77.81%691.75K
75.40%8.74M
15.98%421.6K
436.53%4.85M
99.77%351K
-11.95%3.12M
17.05%4.98M
-54.79%363.5K
48.86%904.3K
-91.54%175.7K
Change In working capital
-69.48%86.87K
420.10%1.76M
201.05%907.35K
156.52%271.02K
362.45%298.63K
60.48%284.64K
81.53%-550.34K
14.91%-897.93K
104.21%105.65K
3.61%64.58K
-Change in receivables
-961.97%-69.6K
-282.70%-30.9K
---38.15K
89.68%-833
--0
--8.08K
-137.07%-8.08K
--0
---8.08K
--0
-Change in prepaid assets
127.63%47.14K
118.50%90.76K
102.86%14.03K
--41.84K
--14.17K
--20.71K
---490.69K
---490.69K
--0
--0
-Change in payables and accrued expense
-57.32%109.29K
3,352.09%1.7M
327.65%926.61K
102.06%230.21K
339.41%284.67K
45.40%256.07K
97.39%-52.2K
62.42%-407.03K
107.56%113.93K
-10.90%64.78K
-Change in other working capital
121.63%45
573.25%4.23K
2,432.21%4.85K
-0.48%-208
0.48%-207
-116.63%-208
100.06%628
36.78%-208
99.98%-207
98.00%-208
Cash from discontinued investing activities
Operating cash flow
-12.94%-1.9M
-86.79%-7.24M
-99.89%-1.69M
-89.54%-1.96M
-84.12%-1.9M
-75.15%-1.68M
13.67%-3.88M
-305.67%-847.35K
71.69%-1.03M
-4,258.20%-1.03M
Investing cash flow
Cash flow from continuing investing activities
-100K
-350K
0
0
Net other investing changes
---100K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---100K
--0
--0
--350K
---350K
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
1.56M
-10.39%4.92M
164.10%1.75M
-103.73%-224.93K
217.50%3.39M
0
-33.21%5.49M
21.39%-2.73M
-29.96%6.03M
77.49%1.07M
Net issuance payments of debt
--1.06M
76.21%-575K
90.55%-200K
-1,350.00%-725K
--350K
--0
-48.98%-2.42M
60.19%-2.12M
-101.05%-50K
--0
Net common stock issuance
--500K
61.77%5.29M
175,141,000.00%1.75M
-62.12%500.07K
343.61%3.04M
--0
-66.92%3.27M
-100.00%1
-48.40%1.32M
-52.76%685.49K
Proceeds from stock option exercised by employees
----
-96.19%200K
29,729.63%200K
--0
----
----
--5.25M
---675
--4.76M
--382.5K
Net other financing activities
----
----
----
----
----
----
-1,107.50%-614.58K
----
----
--0
Cash from discontinued financing activities
Financing cash flow
--1.56M
-10.39%4.92M
164.10%1.75M
-103.73%-224.93K
217.50%3.39M
--0
-33.21%5.49M
21.39%-2.73M
-29.96%6.03M
77.49%1.07M
Net cash flow
Beginning cash position
-61.25%1.47M
73.95%3.79M
-80.85%1.41M
36.43%3.24M
-10.11%2.11M
73.95%3.79M
973.86%2.18M
162.32%7.37M
24.43%2.38M
15.19%2.34M
Current changes in cash
73.89%-439.89K
-244.08%-2.32M
101.61%57.62K
-136.72%-1.83M
3,201.84%1.14M
-1,125.42%-1.68M
-18.46%1.61M
-467.92%-3.58M
455.63%4.99M
127.92%34.47K
End cash Position
-51.15%1.03M
-61.25%1.47M
-61.25%1.47M
-80.85%1.41M
36.43%3.24M
-10.11%2.11M
73.95%3.79M
73.95%3.79M
162.32%7.37M
24.43%2.38M
Free cash flow
-12.94%-1.9M
-86.79%-7.24M
-99.89%-1.69M
-89.54%-1.96M
-84.12%-1.9M
-75.15%-1.68M
37.88%-3.88M
-129.78%-847.35K
86.59%-1.03M
-42.53%-1.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.94%-1.9M-86.79%-7.24M-99.89%-1.69M-89.54%-1.96M-84.12%-1.9M-75.15%-1.68M13.67%-3.88M-305.67%-847.35K71.69%-1.03M-4,259.21%-1.03M
Net income from continuing operations 62.28%-3M43.40%-21.27M-27.61%-3.76M-12.42%-6.35M67.33%-3.2M58.51%-7.96M-179.38%-37.57M-3.64%-2.94M5.01%-5.65M-261.30%-9.8M
Operating gains losses -101.07%-26.73K-92.76%2.05M-85.12%354.03K-132.62%-1.09M-96.54%286.5K-82.46%2.5M429.58%28.26M-2.30%2.38M45.76%3.36M--8.28M
Depreciation and amortization -0.04%250.21K-0.01%1M-0.01%250.31K-0.01%250.31K-0.01%250.31K-0.01%250.31K123.82%1M-43.89%250.35K68,300.55%250.35K68,114.17%250.35K
Other non cash items -77.81%691.75K75.40%8.74M15.98%421.6K436.53%4.85M99.77%351K-11.95%3.12M17.05%4.98M-54.79%363.5K48.86%904.3K-91.54%175.7K
Change In working capital -69.48%86.87K420.10%1.76M201.05%907.35K156.52%271.02K362.45%298.63K60.48%284.64K81.53%-550.34K14.91%-897.93K104.21%105.65K3.61%64.58K
-Change in receivables -961.97%-69.6K-282.70%-30.9K---38.15K89.68%-833--0--8.08K-137.07%-8.08K--0---8.08K--0
-Change in prepaid assets 127.63%47.14K118.50%90.76K102.86%14.03K--41.84K--14.17K--20.71K---490.69K---490.69K--0--0
-Change in payables and accrued expense -57.32%109.29K3,352.09%1.7M327.65%926.61K102.06%230.21K339.41%284.67K45.40%256.07K97.39%-52.2K62.42%-407.03K107.56%113.93K-10.90%64.78K
-Change in other working capital 121.63%45573.25%4.23K2,432.21%4.85K-0.48%-2080.48%-207-116.63%-208100.06%62836.78%-20899.98%-20798.00%-208
Cash from discontinued investing activities
Operating cash flow -12.94%-1.9M-86.79%-7.24M-99.89%-1.69M-89.54%-1.96M-84.12%-1.9M-75.15%-1.68M13.67%-3.88M-305.67%-847.35K71.69%-1.03M-4,258.20%-1.03M
Investing cash flow
Cash flow from continuing investing activities -100K-350K00
Net other investing changes ---100K------------------------------------
Cash from discontinued investing activities
Investing cash flow ---100K--0--0--350K---350K--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 1.56M-10.39%4.92M164.10%1.75M-103.73%-224.93K217.50%3.39M0-33.21%5.49M21.39%-2.73M-29.96%6.03M77.49%1.07M
Net issuance payments of debt --1.06M76.21%-575K90.55%-200K-1,350.00%-725K--350K--0-48.98%-2.42M60.19%-2.12M-101.05%-50K--0
Net common stock issuance --500K61.77%5.29M175,141,000.00%1.75M-62.12%500.07K343.61%3.04M--0-66.92%3.27M-100.00%1-48.40%1.32M-52.76%685.49K
Proceeds from stock option exercised by employees -----96.19%200K29,729.63%200K--0----------5.25M---675--4.76M--382.5K
Net other financing activities -------------------------1,107.50%-614.58K----------0
Cash from discontinued financing activities
Financing cash flow --1.56M-10.39%4.92M164.10%1.75M-103.73%-224.93K217.50%3.39M--0-33.21%5.49M21.39%-2.73M-29.96%6.03M77.49%1.07M
Net cash flow
Beginning cash position -61.25%1.47M73.95%3.79M-80.85%1.41M36.43%3.24M-10.11%2.11M73.95%3.79M973.86%2.18M162.32%7.37M24.43%2.38M15.19%2.34M
Current changes in cash 73.89%-439.89K-244.08%-2.32M101.61%57.62K-136.72%-1.83M3,201.84%1.14M-1,125.42%-1.68M-18.46%1.61M-467.92%-3.58M455.63%4.99M127.92%34.47K
End cash Position -51.15%1.03M-61.25%1.47M-61.25%1.47M-80.85%1.41M36.43%3.24M-10.11%2.11M73.95%3.79M73.95%3.79M162.32%7.37M24.43%2.38M
Free cash flow -12.94%-1.9M-86.79%-7.24M-99.89%-1.69M-89.54%-1.96M-84.12%-1.9M-75.15%-1.68M37.88%-3.88M-129.78%-847.35K86.59%-1.03M-42.53%-1.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg